Year of Award:
2006
Status:
Complete
Award Type:
R43
Project Number:
CA120619
RFA Number:
RFA-CA-06-006
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
LEE, PHILIP J
Other PI or Project Leader:
N/A
Institution:
CELLASIC CORPORATION
External Link:
http://projectreporter.nih.gov/project_info_details.cfm?aid=7085041
The main objective of this proposal is to develop a microfluidic platform for cancer drug toxicity screening in cultured human cells. While it is believed that improved information on a patient's individual cancer signature can aid diagnosis and treatment